Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-28

Clinical Trial Update: Growth Hormone Treatment in Children With Hypophosphatemic Rickets [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of Phase 1 and Phase 2 clinical trials evaluating growth hormone treatment in children with X-Linked Hypophosphatemic Ricke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth Hormone (somatropin)

Snippet

Sponsor: Bicetre Hospital | Conditions: X Linked Hypophosphatemic Rickets | Phase 1, Phase 2 | Status: COMPLETED